|
WO2015142178A1
|
|
Bile acid composition with enhanced solubility
|
|
CN105658205A
|
|
Dry enema product
|
|
CN105658204A
|
|
Method for physically encapsulating, in hydrogel particle, liposome containing active ingredient, and cosmetic composition containing same
|
|
WO2015053620A1
|
|
Betahistine composition
|
|
EP2865371A1
|
|
Fast dissolving granules
|
|
WO2013095111A1
|
|
Simethicone formulation
|
|
EP2425826A1
|
|
Mesalazine tablet having improved dissolution
|
|
AU2010288203A1
|
|
Pharmaceutical compositions for treating IBD
|
|
EP2181705A1
|
|
Sustained-release formulation of gliclazide
|
|
CA2684586A1
|
|
High dose composition of ursodeoxycholic acid
|
|
EP2072043A2
|
|
Mesalazine tablet
|
|
EP1981480A1
|
|
Foam-forming composition
|
|
US6962717B1
|
|
Pharmaceutical compositions
|
